ImpriMed, Inc.
imprimedicine.com
Actively hiring
Veterinary Medicine
Artificial Intelligence
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$23M
1 round on record
Latest round
$23M
Series A · Dec 2023 · 2 yr ago
Team
51-200
employees, estimated range
Backers
2
Draper Associates, Naver D2 Startup Factory
The money's age
Long since its last round
33 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 22, 2024
Launched ImpriMed Unveils Cancer Treatment Prediction Technology at EHA-SfPM Meeting, Expands AI-Driven Precision Medicine Services from Pets to Humans · businesswire.com
Dec 18, 2023
Raised a round Series A $23M
May 24, 2021
Launched ImpriMed Launches Chemo Response Prediction and Immunophenotyping Services for Canine Lymphoma · YahooFinance
2017
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Dec 2023 | $23M | — | businesswire.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Draper Associates 
Naver D2 Startup Factory Similar startupsby what they do, their industry and backers
We’re a veterinary-exclusive pharmacy specializing in custom compounded and commercial veterinary medications. Shipped fast & free.
Scritch is an AI veterinary receptionist built only for veterinary practices that handles appointment scheduling, client phone calls, and…
Vetnio is an AI scribe that records conversations between veterinary professionals and pet owners, automatically generating clinical notes…
VetRec is the #1 AI-powered veterinary scribe. Automate SOAP notes, medical records, and clinical documentation. Try free for 14 days.
Moichor’s Pathview device revolutionizes veterinary diagnostics for dogs, cats, and all species, providing rapid AI-powered hematology and…
GlobalVetLink keeps animal health certificates accurate, submissions on track, and compliance moving. Trusted by 11,000+ veterinary clinics…
News
From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology Pharmacy Times
AI-powered drug response prediction technology is revolutionizing veterinary and human oncology by enabling personalized treatment plans through live cell testing, machine learning models, and data-driven precision medicine approaches.
Read more
Report
Comparative Oncology: Advances in Cancer Care from Pets to Humans Pharmacy Times
Dogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.
Read more
Report
New AI service offers personalized drug response predictions for canine patients with cancer
ImpriMed has announced the launch of the Drug Response Predictions service used to forecast how each dog will respond to certain oncology treatments.
Read more
Report
Flow cytometry and clonality evaluation are effective for characterizing feline lymphoma
A new study showed that this cell-sizing method is useful for characterizing feline lymphoma and predicting patient survival time
Read more
Report
ImpriMed CEO Dr. Sungwon Lim Invited to National Cancer Institute Panel on Commercializing Functional Precision Medicine
ImpriMed CEO Dr. Sungwon Lim to speak at the NCI's functional precision medicine workshop, underscoring the company's leadership in the growing field.
Read more
Report
ImpriMed Unveils Cancer Treatment Prediction Technology at EHA-SfPM Meeting, Expands AI-Driven Precision Medicine Services from Pets to Humans
Read more
Report
ImpriMed: Providing Personalized Medicine For Pets With Blood Cancer Diseases In A $1+ Billion Market
ImpriMed is a company that provides personalized medicine easily accessible for pets with blood cancer diseases. Pulse 2.0 interviewed ImpriMed CEO and co-founder Sungwon Lim to learn more about the company.
Read more
Report
How AI Can Help Treat (and Cure) Your Dog's Cancer
A tech startup wants to use AI to help veterinarians give targeted drugs for a dog's cancer treatment-but is it a helpful tool or are they barking up the wrong tree?
Read more
Report
ImpriMed: Precision Medicine Company Secures $23 Million To Improve Cancer Treatment
ImpriMed - a leading precision medicine startup focused on utilizing AI to improve cancer treatment, recently announced the close of a $23 million Series A funding round, led by SBVA. And HRZ Han River Partners, SK Telecom, KDB Silicon Valley, Ignite Inno
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Palo Alto
United States
Regional office
50-200 est. staff
3980 Fabian Way, Palo Alto, CA, 94303, US
Financials
Total raised
$23M
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2023 | $23M | Details |